CCL
68
-2
NUE
39
-4
A
39
-2
MAS
52
-2
VTR
43
-3
PEP
42
-3
AVB
57
-2
SBUX
32
-9
KR
57
-6
NWS
52
-4
PHM
53
-4
AAPL
64
11
PGR
59
5
SCHW
53
-11
NFLX
74
-2
CMCSA
39
-2
XEL
53
-2
EL
34
-3
ALL
41
6
CSX
44
-2
CCL
68
-2
NUE
39
-4
A
39
-2
MAS
52
-2
VTR
43
-3
PEP
42
-3
AVB
57
-2
SBUX
32
-9
KR
57
-6
NWS
52
-4
PHM
53
-4
AAPL
64
11
PGR
59
5
SCHW
53
-11
NFLX
74
-2
CMCSA
39
-2
XEL
53
-2
EL
34
-3
ALL
41
6
CSX
44
-2
Financhill
Back

Rhoen Klinikum AG 10K Form

Sell
36

RKAGY
Rhoen Klinikum AG

Last Price:
6.05
Seasonality Move:
3.41%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RKAGY News And Ratings

See the #1 stock for the next 7 days that we like better than RKAGY

RKAGY Financial Statistics

Sales & Book Value

Annual Sales: $1.58B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $10.69
Price / Book: 0.57

Profitability

EPS (TTM): 0.36310
Net Income (TTM): $48.63M
Gross Margin: $1.06B
Return on Equity: 3.47%
Return on Assets: 2.49%

Rhoen Klinikum AG Earnings Forecast

Key Rhoen Klinikum AG Financial Ratios

  • The Gross Profit Margin over the past 22 years for RKAGY is 66.63%.
  • The Selling, General & Administrative Expenses for RKAGY have been equal to 4.80% of Gross Profit Margin.
  • The Interest Expense is 9.56% of Operating Income.
  • The Net Earning history of RKAGY is 2.64% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 11 years.

Rhoen Klinikum AG Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: RKAGY
Website: rhoen-klinikum-ag.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.35
Quick Ratio: 2.2

Price-to-Earnings

Trailing P/E Ratio: 19.27
Forward P/E Ratio: 0

RKAGY Technical Analysis vs Fundamental Analysis

Sell
36
Rhoen Klinikum AG (RKAGY) is a Sell

Is Rhoen Klinikum AG a Buy or a Sell?